{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:44:28Z","timestamp":1793727868856,"version":"4.6.1"},"reference-count":116,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"15","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2024,5,20]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>To update an evidence-based guideline to assist in clinical decision-making for patients with advanced hepatocellular carcinoma (HCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>ASCO convened an Expert Panel to update the 2020 guideline on systemic therapy for HCC. The panel updated the systematic review to include randomized controlled trials (RCTs) published through October 2023 and updated recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Ten new RCTs met the inclusion criteria and were added to the evidence base.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RECOMMENDATIONS<\/jats:title>\n                    <jats:p>Atezolizumab + bevacizumab (atezo + bev) or durvalumab + tremelimumab (durva + treme) may be offered first-line for patients with advanced HCC, Child-Pugh class A liver disease, and Eastern Cooperative Oncology Group performance status 0-1. Where there are contraindications to these therapies, sorafenib, lenvatinib, or durvalumab may be offered first-line. Following first-line treatment with atezo + bev, second-line therapy with a tyrosine kinase inhibitor (TKI), ramucirumab (for patients with alpha-fetoprotein [AFP] \u2265400 ng\/mL), durva + treme, or nivolumab + ipilimumab (nivo + ipi) may be recommended for appropriate candidates. Following first-line therapy with durva + treme, second-line therapy with a TKI is recommended. Following first-line treatment with sorafenib or lenvatinib, second-line therapy options include cabozantinib, regorafenib for patients who previously tolerated sorafenib, ramucirumab (AFP \u2265400 ng\/mL), nivo + ipi, or durvalumab; atezo + bev or durva + treme may be considered for patients who did not have access to these therapies in the first-line setting, and do not have contraindications. Pembrolizumab or nivolumab are also options for appropriate patients following sorafenib or lenvatinib. Third-line therapy may be considered in Child-Pugh class A patients with good PS, using one of the agents listed previously that has a nonidentical mechanism of action with previously received therapy. A cautious approach to systemic therapy is recommended for patients with Child-Pugh class B advanced HCC. Further guidance on choosing between options is included within the guideline. Additional information is available at www.asco.org\/gastrointestinal-cancer-guidelines .<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.23.02745","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T15:59:27Z","timestamp":1710863967000},"page":"1830-1850","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":338,"title":["Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update"],"prefix":"10.1200","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8997-5725","authenticated-orcid":false,"given":"John D.","family":"Gordan","sequence":"first","affiliation":[{"name":"University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4370-7757","authenticated-orcid":false,"given":"Erin B.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"American Society of Clinical Oncology, Alexandria, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1522-8054","authenticated-orcid":false,"given":"Ghassan K.","family":"Abou-Alfa","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center and Weill Medical College at Cornell University, New York, NY"},{"name":"Trinity College Dublin Medical School, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2191-6811","authenticated-orcid":false,"given":"Eliza","family":"Beal","sequence":"additional","affiliation":[{"name":"Karmanos Cancer Center, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2494-2126","authenticated-orcid":false,"given":"Richard S.","family":"Finn","sequence":"additional","affiliation":[{"name":"Geffen School of Medicine, UCLA, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-0661","authenticated-orcid":false,"given":"Terence P.","family":"Gade","sequence":"additional","affiliation":[{"name":"Penn Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Goff","sequence":"additional","affiliation":[{"name":"Vanderbilt Ingram Cancer Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpi","family":"Gupta","sequence":"additional","affiliation":[{"name":"Atlantic Medical Group, Morristown, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Guy","sequence":"additional","affiliation":[{"name":"Sutter Health, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang T.","family":"Hoang","sequence":"additional","affiliation":[{"name":"National Cancer Hospital, Hanoi, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3643-8621","authenticated-orcid":false,"given":"Renuka","family":"Iyer","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishmael","family":"Jaiyesimi","sequence":"additional","affiliation":[{"name":"Beaumont Hospital, Royal Oak, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4357-9035","authenticated-orcid":false,"given":"Minaxi","family":"Jhawer","sequence":"additional","affiliation":[{"name":"Englewood Hospital, Englewood, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6516-5824","authenticated-orcid":false,"given":"Asha","family":"Karippot","sequence":"additional","affiliation":[{"name":"Texas Oncology, Plano, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9491-0587","authenticated-orcid":false,"given":"Ahmed O.","family":"Kaseb","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1984-2430","authenticated-orcid":false,"given":"R. Kate","family":"Kelley","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4820-5809","authenticated-orcid":false,"given":"Jeremy","family":"Kortmansky","sequence":"additional","affiliation":[{"name":"Yale Cancer Center, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Leaf","sequence":"additional","affiliation":[{"name":"VA New York Harbor Healthcare System, Brooklyn, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Remak","sequence":"additional","affiliation":[{"name":"California Hepatitis C Task Force, California Chronic Care Coalition, FAIR Foundation, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0182-8403","authenticated-orcid":false,"given":"Davendra P.S.","family":"Sohal","sequence":"additional","affiliation":[{"name":"University of Cincinnati, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6500-1739","authenticated-orcid":false,"given":"Tamar H.","family":"Taddei","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine and VA Connecticut Healthcare System, West Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0680-4993","authenticated-orcid":false,"given":"Andrea","family":"Wilson Woods","sequence":"additional","affiliation":[{"name":"Blue Faery: The Adrienne Wilson Liver Cancer Association, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4401-0748","authenticated-orcid":false,"given":"Mark","family":"Yarchoan","sequence":"additional","affiliation":[{"name":"Johns Hopkins Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0888-5109","authenticated-orcid":false,"given":"Michal G.","family":"Rose","sequence":"additional","affiliation":[{"name":"Yale Cancer Center and VA Connecticut Healthcare System, West Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"b1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"b2","volume-title":"Key Statistics About Liver Cancer","author":"American Cancer Society"},{"key":"b3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3055"},{"key":"b4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"b5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713263"},{"key":"b6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.07.024"},{"key":"b7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21402"},{"key":"b8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.7412"},{"key":"b9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61347-0"},{"key":"b10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.3441"},{"key":"b11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70285-7"},{"key":"b13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745"},{"key":"b15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02672"},{"key":"b16","doi-asserted-by":"publisher","DOI":"10.17998\/jlc.2023.02.23"},{"key":"b17","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04206-8"},{"key":"b18","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-23-0072"},{"key":"b19","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604"},{"key":"b20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2010.02530.x"},{"key":"b21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1717002"},{"key":"b22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32453-9"},{"key":"b23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30207-1"},{"key":"b24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857"},{"key":"b25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01307"},{"key":"b26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30937-9"},{"key":"b27","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00604-5"},{"key":"b28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.030"},{"key":"b29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00961-3"},{"key":"b30","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00252-7"},{"key":"b31","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100070"},{"key":"b32","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00326-6"},{"key":"b33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00392"},{"key":"b34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00163"},{"key":"b35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00620"},{"key":"b36","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00109-6"},{"key":"b37","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.4003"},{"key":"b38","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.08.031"},{"key":"b39","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz446.002"},{"key":"b41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.04.010"},{"key":"b42","volume-title":"Clinical Practice Guidelines in oncology (NCCN Guidelines): Hepatobiliary Cancers","author":"National Comprehensive Cancer Network","year":"2020"},{"key":"b43","volume-title":"FDA Approves Nivolumab Plus Ipilimumab in Advanced Hepatocellular Carcinoma","author":"Tucker N"},{"key":"b44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.047"},{"key":"b45","volume-title":"Bristol-myers Squibb Announces First Presentation of Results for Opdivo (Nivolumab) Plus Yervoy (Ipilimumab) Combination in Advanced Hepatocellular Carcinoma at ASCO 2019 [news release]","author":"Bristol Myers Squibb","year":"2019"},{"key":"b47","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00050-9"},{"key":"b48","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i7.789"},{"key":"b49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235966"},{"key":"b50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31046-2"},{"key":"b51","volume-title":"Bristol Myers Squibb Statement on Opdivo\u00ae (Nivolumab) Monotherapy Post-Sorafenib Hepatocellular Carcinoma U.S. Indication","year":"2021"},{"key":"b53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.047"},{"key":"b54","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2018.1479070"},{"key":"b55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.09.031"},{"key":"b56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.07.020"},{"key":"b57","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32206"},{"key":"b58","doi-asserted-by":"publisher","DOI":"10.1177\/17588359221148541"},{"key":"b59","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32468"},{"key":"b60","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17441"},{"key":"b61","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S256691"},{"key":"b62","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.3284"},{"key":"b63","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30351-6"},{"key":"b64","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz394.029"},{"key":"b66","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyq055"},{"key":"b67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2019.11.009"},{"key":"b68","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2018.07.05"},{"key":"b69","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26682"},{"key":"b70","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001391"},{"key":"b71","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16448"},{"key":"b72","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15617"},{"key":"b73","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16448"},{"key":"b74","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174345"},{"key":"b75","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318934"},{"key":"b76","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.4_suppl.489"},{"key":"b77","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.019729"},{"key":"b78","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyx087"},{"key":"b79","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy6010023"},{"key":"b80","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy8010046"},{"key":"b81","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.17.00039"},{"key":"b82","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.2311"},{"key":"b83","volume-title":"Cancer Facts & Figures for African Americans 2016-2018","author":"American Cancer Society","year":"2016"},{"key":"b84","volume-title":"United States Cancer Statistics: 1999\u20132012 Incidence and Mortality Web-Based Report","author":"United States Cancer Statistics Working Group","year":"2015"},{"key":"b85","volume-title":"Racial and Ethnic Disparities in U.S. Health Care: A Chartbook","author":"Mead H","year":"2008"},{"key":"b86","volume-title":"SEER Cancer Statistics Review","author":"Howlader N","year":"1975"},{"key":"b87","volume-title":"Viral Hepatitis","author":"Centers for Disease Control and Prevention"},{"key":"b88","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30103"},{"key":"b89","first-page":"43","volume":"5","author":"Xu L","year":"2016","journal-title":"Hepatobiliary Surg Nutr"},{"key":"b90","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2010.272"},{"key":"b91","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24817"},{"key":"b92","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1299"},{"key":"b93","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0261-y"},{"key":"b94","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.05.039"},{"key":"b95","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2018.05.030"},{"key":"b96","volume-title":"Understanding Disparities in Clinical Trial Enrollment","author":"The Johns Hopkins Hospital"},{"key":"b97","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26221"},{"key":"b98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2018.10.003"},{"key":"b99","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1552432"},{"key":"b100","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0501"},{"key":"b101","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-019-01554-0"},{"key":"b102","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14257"},{"key":"b103","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28881"},{"key":"b104","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30863"},{"key":"b105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207132"},{"key":"b106","doi-asserted-by":"publisher","DOI":"10.1177\/1756284819878304"},{"key":"b107","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.7275"},{"key":"b108","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1707211"},{"key":"b109","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26231"},{"key":"b110","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.100"},{"key":"b111","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2011.000316"},{"key":"b112","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.9123"},{"key":"b113","doi-asserted-by":"publisher","DOI":"10.25270\/jcp.2019.06.00083"},{"key":"b114","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2018.05.020"},{"key":"b115","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.6620"},{"key":"b116","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.1183"},{"key":"b117","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.1474"},{"key":"b118","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.0441"},{"key":"b119","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2021.03.007"},{"key":"b120","volume-title":"Degendering Oncologic Care and Other Recommendations to Eliminate Barriers to Care for Transgender People with Cancer","author":"Alpert AB"},{"key":"b121","volume-title":"Transgender Care & Treatment Guidelines","author":"University of California, San Francisco"},{"key":"b122","volume-title":"Understanding Transgender People: The Basics","author":"National Center for Transgender Equality"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.23.02745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T18:00:47Z","timestamp":1715796047000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.23.02745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":116,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,5,20]]}},"alternative-id":["10.1200\/JCO.23.02745"],"URL":"https:\/\/doi.org\/10.1200\/jco.23.02745","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,20]]},"assertion":[{"value":"2023-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}